- Retraction Note
- Open Access
- Published:
Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
Cancer Cell International volume 13, Article number: 96 (2013)
- The original article was published in Cancer Cell International 2012 12:21
Retraction
This article has been retracted [1] by the authors because errors were noted in the methodology employed in the experiments which invalidate the results reported. The authors apologise for any inconvenience caused.
References
- 1.
Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186/1475-2867-12-21.
Author information
Additional information
The online version of the original article can be found at 10.1186/1475-2867-12-21
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Jelly, N.D., Hussain, I.I., Eremin, J. et al. Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int 13, 96 (2013). https://doi.org/10.1186/1475-2867-13-96
Received:
Accepted:
Published:
